Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2022

01-03-2022 | Neutropenia | Case report

Etoposide

Febrile neutropenia: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
…
Literature
Zhu Y, et al. A Risk-Prediction Nomogram for Neutropenia or Febrile Neutropenia after Etoposide-Based Chemotherapy in Cancer Patients: A Retrospective Cohort Study. Pharmacology 107: 69-80, No. 1, Jan 2022. Available from: URL: http://​doi.​org/​10.​1159/​000519333
Metadata
Title
Etoposide
Febrile neutropenia: case report
Publication date
01-03-2022
Publisher
Springer International Publishing
Keyword
Neutropenia
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-12162-z

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Testosterone

Case report

Rosuvastatin

Case report

Cyclophosphamide/doxorubicin/tamoxifen

Case report

Antiepileptic drugs/praziquantel

Case report

Dapagliflozin

Case report

Antiparkinsonians